Fund Universe

Vestal Point Capital, LP

CIK 0001974915 · holdings for 2026Q2 (change vs 2026Q1) · in signal universe
Quality Q
0.263
AUM ($M)
4,279
Positions
68
Turnover
0.38
Top-10 wt
50%
Herfindahl
0.036
History (qtrs)
6
Excess Return

AI Eval Run AI Eval

No AI Eval requested yet for this fund.
Quarter
Activity this period
Security type

Holdings · 101 positions · portfolio value $4,279M

TickerNameActivitySecurity Type WeightΔ Weight Value ($M)SharesΔ Shares Qtrs HeldExcess Return
BMRN funds › BioMarin Pharmaceutical Inc ADD 8.1% +2.4% 344.8 6,025,000 +2,450,000 5
NBIX funds › Neurocrine Biosciences Inc ADD 7.4% +2.8% 316.8 1,880,000 +630,000 2
ABVX funds › Abivax SA ADD 7.3% +2.6% 313.1 2,349,443 +849,443 4
UTHR funds › United Therapeutics Corp ADD 5.5% +4.3% 235.7 435,000 +360,000 2
ELVN funds › Enliven Therapeutics Inc ADD 4.7% +1.2% 203.0 4,000,000 +750,000 5
NRIX funds › Nurix Therapeutics Inc ADD 4.6% +1.7% 195.3 8,050,000 +1,550,000 5
BCAX funds › Bicara Therapeutics Inc TRIM 3.6% +0.6% 155.9 5,250,000 -175,000 5
TSHA funds › Taysha Gene Therapies Inc ADD 3.1% +0.8% 132.2 19,415,000 +1,415,000 5
ARWR funds › Arrowhead Pharmaceuticals Inc TRIM 3.0% -1.0% 128.4 1,575,000 -700,000 3
ABT funds › Abbott Laboratories NEW 3.0% +3.0% 127.0 1,400,000 +1,400,000 1
ZBH funds › Zimmer Biomet Holdings Inc ADD 2.8% +2.3% 120.5 1,400,000 +1,210,000 3
IRON funds › Disc Medicine Inc ADD 2.6% +1.4% 113.4 1,550,000 +850,000 5
GLUE funds › Monte Rosa Therapeutics Inc ADD 2.6% +0.9% 111.3 4,600,000 +996,535 4
PODD funds › Insulet Corp ADD 2.4% +2.1% 102.0 670,000 +619,399 2
ASND funds › Ascendis Pharma A/S NEW 2.3% +2.3% 100.0 375,000 +375,000 1
AZN funds › AstraZeneca PLC ADD 2.0% +1.4% 85.3 450,000 +350,000 2
SNY funds › Sanofi SA ADD 2.0% +0.1% 85.3 2,000,000 +600,000 2
RVMD funds › Revolution Medicines Inc TRIM 2.0% -4.5% 84.3 450,000 -1,925,000 5
BCRX funds › BioCryst Pharmaceuticals Inc ADD 1.9% +0.1% 83.0 8,300,000 +1,275,000 3
DYN funds › Dyne Therapeutics Inc TRIM 1.8% -0.3% 75.0 3,375,000 -625,000 5
NKTR funds › Nektar Therapeutics ADD 1.6% +1.1% 69.8 1,000,000 +715,000 2
GMED funds › Globus Medical Inc ADD 1.6% +0.1% 67.2 850,000 +239,480 5
TARS funds › Tarsus Pharmaceuticals Inc ADD 1.5% +1.2% 66.1 1,050,000 +850,000 2
IMTX funds › Immatics NV HOLD 1.5% -0.2% 62.6 6,175,000 +0 5
TRVI funds › Trevi Therapeutics Inc ADD 1.4% +0.6% 57.8 3,100,000 +933,496 2
IMCR funds › Immunocore Holdings PLC TRIM 1.3% -1.0% 57.1 1,800,000 -966,868 3
RGEN funds › Repligen Corp TRIM 1.3% -1.8% 54.6 400,000 -525,000 4
BMY funds › Bristol-Myers Squibb Co TRIM 1.1% -0.6% 46.1 800,000 -200,000 3
QURE funds › uniQure NV ADD 1.0% +0.8% 43.1 935,000 +576,004 2
XENE funds › Xenon Pharmaceuticals Inc ADD 1.0% -0.1% 42.3 700,000 +60,100 5
DRUG funds › Bright Minds Biosciences Inc ADD 0.9% -0.1% 38.3 545,000 +52,681 2
MDGL funds › Madrigal Pharmaceuticals Inc ADD 0.8% +0.4% 34.9 65,000 +33,532 2
ALC funds › Alcon AG TRIM 0.8% -0.9% 33.5 500,000 -300,000 5
MYGN funds › Myriad Genetics Inc ADD 0.8% +0.6% 32.7 5,735,000 +4,087,000 4
RAPP funds › Rapport Therapeutics Inc TRIM 0.7% -0.5% 30.4 730,000 -706,229 4
CBIO funds › Crescent Biopharma Inc ADD 0.7% -0.1% 29.3 1,630,000 +130,000 3
GEHC funds › GE HealthCare Technologies Inc ADD 0.7% +0.2% 28.8 450,000 +200,000 2
INSM funds › Insmed Inc NEW 0.6% +0.6% 26.7 250,000 +250,000 1
VKTX funds › Viking Therapeutics Inc TRIM 0.6% -0.2% 26.5 680,000 -234,147 2
BBNX funds › Beta Bionics Inc TRIM 0.6% -0.0% 25.1 1,600,000 -611,518 5
REGN funds › Regeneron Pharmaceuticals Inc HOLD 0.6% -0.3% 24.9 40,000 +0 2
SLDB funds › Solid Biosciences Inc TRIM 0.5% -0.5% 21.6 2,160,000 -2,840,000 5
ANRO funds › Alto Neuroscience Inc TRIM 0.5% -0.8% 20.7 785,000 -1,279,075 5
TRAX funds › First Tracks Biotherapeutics I NEW 0.5% +0.5% 20.4 1,013,000 +1,013,000 1
LXEO funds › Lexeo Therapeutics Inc TRIM 0.5% -0.2% 20.1 4,320,000 -155,000 5
SVRA funds › Savara Inc ADD 0.4% -0.0% 16.8 2,720,000 +119,948 5
DMRA funds › Damora Therapeutics Inc TRIM 0.3% -0.1% 15.0 575,000 -25,000 2
SGP funds › SpyGlass Pharma Inc ADD 0.3% -0.1% 14.9 670,000 +3,240 2
TECX funds › Tectonic Therapeutic Inc ADD 0.3% +0.1% 14.6 425,000 +97,000 3
AVTX funds › Avalo Therapeutics Inc NEW 0.3% +0.3% 14.3 775,000 +775,000 1
EVMN funds › Evommune Inc NEW 0.3% +0.3% 13.3 1,000,000 +1,000,000 1
KLRA funds › Kailera Therapeutics Inc NEW 0.3% +0.3% 12.7 575,000 +575,000 1
AVR funds › Anteris Technologies Global Co TRIM 0.2% +0.1% 9.9 1,010,000 -134,780 2
ZBIO funds › Zenas Biopharma Inc ADD 0.2% +0.1% 9.3 365,000 +165,000 2
VYGR funds › Voyager Therapeutics Inc TRIM 0.2% -0.1% 9.2 2,625,000 -377,936 5
OKUR funds › OnKure Therapeutics Inc TRIM 0.2% -0.0% 8.3 1,825,699 -14,120 5
SRZN funds › Surrozen Inc TRIM 0.2% -0.1% 7.9 304,669 -33,942 2
MNPR funds › Monopar Therapeutics Inc ADD 0.2% +0.1% 7.0 75,727 +10,309 2
ZURA funds › Zura Bio Ltd ADD 0.2% +0.1% 6.9 1,173,956 +662,956 2
OLMA funds › Olema Pharmaceuticals Inc TRIM 0.1% -0.1% 5.2 418,551 -10,000 3
PALI funds › Palisade Bio Inc HOLD 0.1% -0.0% 5.2 2,500,000 +0 2
IBIO funds › iBio Inc NEW 0.1% +0.1% 4.5 2,600,000 +2,600,000 1
SGMT funds › Sagimet Biosciences Inc NEW 0.1% +0.1% 4.1 535,452 +535,452 1
ENGN funds › enGene Therapeutics Inc NEW 0.1% +0.1% 2.9 1,667,430 +1,667,430 1
RZLT funds › Rezolute Inc NEW 0.0% +0.0% 2.0 382,999 +382,999 1
NYXH funds › Nyxoah SA TRIM 0.0% -0.0% 1.4 843,461 -25,200 5
TENX funds › Tenax Therapeutics Inc HOLD 0.0% -0.0% 0.8 53,439 +0 5
APRE funds › Aprea Therapeutics Inc HOLD 0.0% -0.0% 0.3 350,000 +0 2
AGIO funds › Agios Pharmaceuticals Inc EXIT 0.0% -0.4% 0.0 0 -450,000 0
SRRK funds › Scholar Rock Holding Corp EXIT 0.0% -1.8% 0.0 0 -1,324,422 0
COGT funds › Cogent Biosciences Inc EXIT 0.0% -1.3% 0.0 0 -1,230,888 0
APGE funds › Apogee Therapeutics Inc EXIT 0.0% -2.6% 0.0 0 -1,100,000 0
CADL funds › Candel Therapeutics Inc EXIT 0.0% -0.2% 0.0 0 -1,125,000 0
CYTK funds › Cytokinetics Inc EXIT 0.0% -0.6% 0.0 0 -300,000 0
VERA funds › Vera Therapeutics Inc EXIT 0.0% -1.5% 0.0 0 -1,368,159 0
WGS funds › GeneDx Holdings Corp EXIT 0.0% -0.4% 0.0 0 -250,000 0
BSX funds › Boston Scientific Corp EXIT 0.0% -1.4% 0.0 0 -800,000 0
CLDX funds › Celldex Therapeutics Inc EXIT 0.0% -1.1% 0.0 0 -1,224,165 0
DNLI funds › Denali Therapeutics Inc EXIT 0.0% -1.0% 0.0 0 -1,773,326 0
INSP funds › Inspire Medical Systems Inc EXIT 0.0% -0.8% 0.0 0 -539,269 0
FULC funds › Fulcrum Therapeutics Inc EXIT 0.0% -0.2% 0.0 0 -1,100,000 0
CUSIP:29286M105 funds › enGene Therapeutics Inc EXIT 0.0% -0.4% 0.0 0 -2,165,000 0
ARVN funds › Arvinas Inc EXIT 0.0% -0.3% 0.0 0 -905,465 0
PTGX funds › Protagonist Therapeutics Inc EXIT 0.0% -1.0% 0.0 0 -326,159 0
TYRA funds › Tyra Biosciences Inc EXIT 0.0% -0.1% 0.0 0 -54,000 0
URGN funds › UroGen Pharma Ltd EXIT 0.0% -0.1% 0.0 0 -139,079 0
WAT funds › Waters Corp EXIT 0.0% -0.8% 0.0 0 -100,000 0
PASG funds › Passage Bio Inc EXIT 0.0% -0.1% 0.0 0 -305,000 0
WST funds › West Pharmaceutical Services I EXIT 0.0% -0.5% 0.0 0 -75,000 0
ABSI funds › Absci Corp EXIT Common Stock 0.0% -0.0% 0.0 0 -232,219 0
NUVL funds › Nuvalent Inc EXIT 0.0% -1.4% 0.0 0 -481,715 0
CUSIP:483497103 funds › KalVista Pharmaceuticals Inc EXIT 0.0% -1.0% 0.0 0 -1,850,000 0
MGNX funds › MacroGenics Inc EXIT 0.0% -0.0% 0.0 0 -280,000 0
CUSIP:834203309 funds › Soleno Therapeutics Inc EXIT 0.0% -0.7% 0.0 0 -730,000 0
CUSIP:880881107 funds › Terns Pharmaceuticals Inc EXIT 0.0% -1.5% 0.0 0 -1,000,000 0
MPLT funds › MapLight Therapeutics Inc EXIT 0.0% -0.2% 0.0 0 -420,000 0
VCYT funds › Veracyte Inc EXIT 0.0% -0.1% 0.0 0 -130,687 0
NVCR funds › Novocure Ltd EXIT 0.0% -0.1% 0.0 0 -250,000 0
RGNX funds › REGENXBIO Inc EXIT 0.0% -0.0% 0.0 0 -108,525 0
CUSIP:04351P101 funds › Ascendis Pharma A/S EXIT 0.0% -2.4% 0.0 0 -375,000 0
GERN funds › Geron Corp EXIT 0.0% -0.1% 0.0 0 -2,540,000 0

Point-in-time history

Each row is this fund as of that period, not as of today — what the scoring for that quarter actually saw.
PeriodAUM ($M)Positions TurnoverTop-10 wtHerfindahl Quality Q Skill Universe
2026Q2 4,279 68 0.38 50% 0.036 0.261 in
2026Q1 3,577 90 0.49 40% 0.026 0.087 in
2025Q4 2,726 75 0.49 49% 0.036 0.079 in
2025Q3 2,204 80 0.41 39% 0.024 0.091 in
2025Q2 1,899 72 0.33 45% 0.033 0.223 entered
2025Q1 1,400 63 0.00 51% 0.040 0.000 out
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status